Harpoon Therapeutics HARP

$ 23.01 0.0%

Quarterly report 2023-Q3
added 11-09-2023

Harpoon Therapeutics Balance Sheet 2011-2024 | HARP

Annual Balance Sheet Harpoon Therapeutics

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-35.6 M	-32.5 M	-	-73.8 M	-89.5 M	-29.4 M	1.33 M	-	-	-	-	-
Long Term Debt	13.6 M	10.5 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	2.42 M	1.65 M	1.2 M	1.22 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	59.9 M	144 M	51.9 M	15 M	-	-	-	-	-
Total Current Liabilities	52.4 M	59.1 M	47.9 M	22.5 M	11.9 M	-	-	-	-	-	-	-
Total Liabilities	68.3 M	97.4 M	118 M	82.4 M	156 M	58.8 M	18.8 M	-	-	-	-	-
Deferred Revenue	30.9 M	37.5 M	31.3 M	11.2 M	4.25 M	4.25 M	-	-	-	-	-	-
Retained Earnings	-353 M	-285 M	-168 M	-118 M	-62.6 M	-35.2 M	-18.4 M	-	-	-	-	-
Total Assets	73.7 M	155 M	172 M	177 M	103 M	31.9 M	8.38 M	-	-	-	-	-
Cash and Cash Equivalents	51.6 M	44.7 M	21.2 M	88.7 M	89.5 M	29.4 M	985 K	-	-	-	-	-
Book Value	5.4 M	58.1 M	53.8 M	94.2 M	-53.5 M	-26.9 M	-10.4 M	-	-	-	-	-
Total Shareholders Equity	5.4 M	58.1 M	53.8 M	94.2 M	-53.5 M	-26.9 M	-10.4 M	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Harpoon Therapeutics

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	11.5 M	12.3 M	12.8 M	13.6 M	9.14 M	9.63 M	10.1 M	10.5 M	11 M	11.4 M	11.8 M	12.3 M	12.3 M	12.3 M	12.3 M	13.7 M	13.7 M	13.7 M	13.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	43 M	60.2 M	80.1 M	68.3 M	66.6 M	82.3 M	91.1 M	97.4 M	97.7 M	105 M	159 M	118 M	118 M	118 M	118 M	82.4 M	82.4 M	82.4 M	82.4 M	26.5 M	26.5 M	26.5 M	26.5 M	19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	4.45 M	22.4 M	30.9 M	34 M	36.5 M	36.9 M	37.5 M	38.1 M	34.8 M	30.8 M	31.3 M	31.3 M	31.3 M	31.3 M	11.2 M	11.2 M	11.2 M	11.2 M	4.25 M	4.25 M	4.25 M	4.25 M	4.25 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-365 M	-363 M	-364 M	-353 M	-334 M	-322 M	-305 M	-285 M	-263 M	-247 M	-230 M	-168 M	-168 M	-168 M	-168 M	-118 M	-118 M	-118 M	-118 M	-62.6 M	-62.6 M	-62.6 M	-62.6 M	-35.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	47.6 M	63.2 M	80.8 M	73.7 M	83.5 M	109 M	132 M	155 M	175 M	196 M	261 M	172 M	172 M	172 M	172 M	177 M	177 M	177 M	177 M	103 M	103 M	103 M	103 M	31.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	17.7 M	32.8 M	61.4 M	51.6 M	51 M	69.2 M	50.7 M	44.7 M	43 M	77.4 M	71.3 M	21.2 M	21.2 M	21.2 M	21.2 M	88.7 M	88.7 M	88.7 M	88.7 M	89.5 M	89.5 M	89.5 M	89.5 M	29.4 M	-	-	-	985 K	-	-	-	2.35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	4.54 M	3 M	715 K	5.4 M	16.9 M	26.6 M	41.4 M	58.1 M	77 M	90.9 M	102 M	53.8 M	53.8 M	53.8 M	53.8 M	94.2 M	94.2 M	94.2 M	94.2 M	76.1 M	76.1 M	76.1 M	76.1 M	12.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	4.54 M	3 M	604 K	5.4 M	16.9 M	26.6 M	41.4 M	58.1 M	77 M	90.9 M	102 M	53.8 M	53.8 M	53.8 M	53.8 M	94.2 M	94.2 M	94.2 M	94.2 M	-53.5 M	-53.5 M	-53.5 M	-53.5 M	-26.9 M	-	-	-	-10.4 M	-	-	-	-6.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency